Effect of Nonsurgical Mechanical Debridement With or Without Chlorhexidine Formulations in the Treatment of Peri-Implant Mucositis. A Randomized Placebo-Controlled Clinical Trial
- PMID: 39865359
- PMCID: PMC12066909
- DOI: 10.1111/clr.14405
Effect of Nonsurgical Mechanical Debridement With or Without Chlorhexidine Formulations in the Treatment of Peri-Implant Mucositis. A Randomized Placebo-Controlled Clinical Trial
Abstract
Objectives: To evaluate the treatment of peri-implant mucositis (PM) using a nonsurgical submarginal peri-implant instrumentation (NSPI) with or without chlorhexidine (CHX) solutions.
Methods: Fifty-six patients (28 per group) were randomly assigned to the test (NSPI + 0.12% mouthwash and subgingival CHX irrigation plus tongue brushing with 1% CHX gel) or the control group (NSPI + placebo mouthwash and subgingival placebo irrigation plus tongue brushing with placebo gel). At baseline, 1, 3, 6 months, bleeding on probing (BOP), probing pocket depth (PPD), modified gingival index (mGI), modified plaque index (mPlI), full-mouth plaque score (FMPS), full-mouth bleeding score (FMBS), and the proportions of Aggregatibacter actinomycetemcomitans , Porphyromonas gingivalis , Tannerella forsythia, and Treponema denticola were recorded. The BOP reduction was set as a primary outcome. Data were analyzed to assess BOP reduction at a 6-month follow-up and to identify significant predictors of implant-site BOP through mixed generalized linear regression.
Results: After 6 months in both groups, a significant reduction of BOP, PD, mPlI, mGI, FMBS, and FMPS was noted (p < 0.05). However, at 6 months, the test group was more effective than the controls in reducing median BOP (∆values control/test: 39.3% [95% CI 37.4-42.3] vs. 48.7 [95% CI 46.5-51.2], p = 0.044), as well as mPlI (p = 0.041) and the proportion of Treponema denticola (p = 0.039). Moreover, the implant-sites BOP reduction was significantly influenced by test treatment (p < 0.001), history of periodontitis (p = 0.003), and a high number of cigarettes/day (p = 0.002), the proportion of Porphyromonas gingivalis (p = 0.021) and Tannerella forsythia (p = 0.032).
Conclusions: NSPI + CHX showed better results compared to placebo in implant-sites BOP reduction. The high number of cigarettes/day and the proportion of Porphyromonas gingivalis and T. forsythia negatively influenced the BOP reduction in PM-treated patients.
Keywords: biofilm; bleeding on probing; clinical trial; inflammation; mucositis; smoking.
© 2025 The Author(s). Clinical Oral Implants Research published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Alasqah, M. N. , Alfawaz Y. F., Aldahiyan N., Vohra F., Alotaibi B. M., and Abduljabbar T.. 2019. “Longitudinal Assessment of Clinical and Radiographic Periimplant Status Around Narrow and Regular Diameter Implants Placed in Cigarette‐Smokers and Nonsmokers.” Clinical Implant Dentistry and Related Research 21, no. 5: 910–915. 10.1111/cid.12751. - DOI - PubMed
-
- Alqutub, M. N. , Alhumaidan A. A., Alali Y., et al. 2023. “Comparison of the Postoperative Anti‐Inflammatory Efficacy of Chlorhexidine, Saline Rinses and Herbal Mouthwashes After Mechanical Debridement in Patients With Peri‐Implant Mucositis: A Randomized Controlled Trial.” International Journal of Dental Hygiene 21, no. 1: 203–210. 10.1111/idh.12582. - DOI - PubMed
-
- Annunziata, M. , Cecoro G., Guida A., et al. 2024. “Effectiveness of Implant Therapy in Patients With and Without a History of Periodontitis: A Systematic Review With Meta‐Analysis of Prospective Cohort Studies.” Journal of Periodontal Research. Published ahead of print, October 28, 2024. 10.1111/jre.13351. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
